Seung J. Kim
St. Vincent's Hospital
Suwon, Republic of Korea
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 126 publications
Evaluation of in vitro blood-brain barrier models in central nervous system new drug development: methodological challenges and translational perspectives.
Journal: Expert opinion on drug delivery
Published: June 01, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort study.
Journal: Translational lung cancer research
Published: October 25, 2025
Temporal changes in tongue color during immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer: a prospective observational study using digital tongue diagnosis.
Journal: Oncology reviews
Published: September 02, 2025
Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients.
Journal: Thoracic cancer
Published: August 14, 2025
Single-nucleus multi-omics delineates distinct epigenetic programs associated with tumor progression in lung adenocarcinoma.
Journal: Clinical epigenetics
Published: August 07, 2025
Reproductive Dysfunction in Experimental Autoimmune Encephalomyelitis, an Animal Model of Multiple Sclerosis.
Journal: Experimental neurobiology
Published: June 09, 2025
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial.
Journal: Integrative cancer therapies
Published: February 22, 2025
Enhanced application potential of alveolar organoids through epithelial and niche cell interactions.
Enhanced application potential of alveolar organoids through epithelial and niche cell interactions.
Journal: Scientific reports
Published: February 10, 2025
Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements.
Journal: Therapeutic advances in medical oncology
Published: October 27, 2024
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations.
Journal: Integrative cancer therapies
Published: August 05, 2024
Lung cancer organoid-based drug evaluation models and new drug development application trends.
Journal: Translational lung cancer research
Published: July 20, 2024
Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation.
Journal: The clinical respiratory journal
Published: May 27, 2024
Last Updated: 09/26/2026